Open | - |
Close | - |
Volume / Avg. | 4.726K / 527.579K |
Day Range | - - - |
52 Wk Range | 1.240 - 12.750 |
Market Cap | $37.489M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 10.19% |
Days to Cover | 5.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Fortress Biotech (NASDAQ: FBIO) through any online brokerage.
Other companies in Fortress Biotech’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Sensei Biotherapeutics (NASDAQ:SNSE), Eledon Pharma (NASDAQ:ELDN) and Viracta Therapeutics (NASDAQ:VIRX).
The latest price target for Fortress Biotech (NASDAQ: FBIO) was reported by Roth MKM on Friday, March 15, 2024. The analyst firm set a price target for 10.00 expecting FBIO to rise to within 12 months (a possible 390.20% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Fortress Biotech (NASDAQ: FBIO) is $2.04 last updated Today at March 19, 2024 at 6:04 AM EDT.
There are no upcoming dividends for Fortress Biotech.
Fortress Biotech’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Fortress Biotech.
Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.